ארקסווי

Country: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

RSVPREF3 ANTIGEN

Disponibbli minn:

GLAXO SMITH KLINE (ISRAEL) LTD

Għamla farmaċewtika:

אבקה ותרחיף להכנת תרחיף להזרקה

Kompożizzjoni:

RSVPREF3 ANTIGEN 163 MCG/VIAL

Rotta amministrattiva:

תוך-שרירי

Tip ta 'preskrizzjoni:

מרשם נדרש

Manifatturat minn:

GLAXO SMITH KLINE BIOLOGICALS S.A

Data ta 'l-awtorizzazzjoni:

2023-12-26

Fuljett ta 'informazzjoni

Page 1 of 6
ʥ"ʮʹʺʤ (ʭʩʸʩʹʫʺ) ʭʩʧʷʥʸʤ ʺʥʰʷʺ ʩʴʬ
ʯʫʸʶʬ ʯʥʬʲ
–
1986
ʣʡʬʡ ʠʴʥʸ ʭʹʸʮ ʩʴ ʬʲ ʺʷʥʥʹʮ ʤʴʥʸʺʤ
ʩʥʥʱʷʸʠ
ʬ ʳʩʧʸʺʥ ʤʷʡʠ
ʺʰʫʤ
ʤʷʸʦʤʬ ʳʩʧʸʺ
ʯʥʷʥʡʷʡ ,ʤʰʫʤ ʩʰʴʬ
ʤ
(ʯʢʩʨʰʠ) ʤʷʡʠ
:ʬʩʫʮ
RSVPreF3
1
antigen
163 micrograms
,ʤʰʫʤ ʸʧʠʬ
) ʤʰʮ ʬʫ
0.5
:ʤʬʩʫʮ (ʬ"ʮ
RSVPreF3
1
antigen
120 micrograms
1
Respiratory Syncytial Virus recombinant glycoprotein F stabilized in
the pre-fusion
conformation
ʥ ʭʩʬʩʲʴ ʩʺʬʡʤ ʭʩʸʮʥʧʤ ʺʮʩʹʸʬ
ʤ
ʭʩʩʰʢʸʬʠ
ʸʩʹʫʺʡ
ʳʩʲʱ ʤʠʸ
2
-
ʷʬʧ ʬʲ ʡʥʹʧ ʲʣʩʮ"
ʳʩʲʱʥ "ʤʴʥʸʺʤ ʬʹ ʭʩʡʩʫʸʮʤʮ
6
."ʳʱʥʰ ʲʣʩʮ"
.ʤʴʥʸʺʡ ʹʮʺʹʺ ʭʸʨʡ ʥʴʥʱ ʣʲ ʯʥʬʲʤ ʺʠ
ʯʥʩʲʡ ʠʸʷ
ʬʲ ʩʺʩʶʮʺ ʲʣʩʮ ʬʩʫʮ ʤʦ ʯʥʬʲ
.ʧʷʥʸʤ ʥʠ ʠʴʥʸʤ ʬʠ ʤʰʴ ,ʺʥʴʱʥʰ ʺʥʬʠʹ ʪʬ
ʹʩ ʭʠ .ʤʴʥʸʺʤ
ʠʩʤ .ʭʩʸʧʠʬ ʤʺʥʠ ʸʩʡʲʺ ʬʠ .ʪʸʥʡʲ ʤʮʹʸʰ
ʥʦ ʤʴʥʸʺ
ʤʠʸʰ ʭʠ ʥʬʩʴʠ ʭʤʬ ʷʩʦʤʬ ʤʬʥʬʲ
.ʤʮʥʣ ʩʠʥʴʸʤ ʭʡʶʮ ʩʫ ʪʬ
1
.
?ʤʴʥʸʺʤ ʺʣʲʥʩʮ ʤʮʬ
ʱʥʸʩʥ ʩʣʩ ʬʲ ʺʥʮʸʢʰʤ ʺʥʰʥʺʧʺʤ ʤʮʩʹʰʤ
ʩʫʸʣʡ ʺʥʬʧʮ ʺʲʩʰʮʬ ʬʩʲʴ ʯʥʱʩʧ ʥʰʩʤ
ʩʥʥʱʷʸʠ
ʩʺʮʩʹʰ ʩʬʠʩʶʰʩʱ
(RSV-respiratory syncytial virus)
ʬʩʢʮ ʭʩʸʢʥʡʮʡ
60
.ʤʬʲʮʥ ʭʩʰʹ
ʺʩʨʩʥʴʸʺ ʤʶʥʡʷ
:
ʣʢʰʫ ʭʩʰʥʱʩʧ
ʩʺʮʩʹʰ ʩʬʠʩʶʰʩʱ ʱʥʸʩʥ
.
ʩʺʮʩʹʰ ʩʬʠʩʶʰʩʱ ʱʥʸʩʥ
.ʤʡʸ ʺʥʬʷʡ ʨʹʴʺʮʹ ʩʺʮʩʹʰ ʱʥʸʩʥ ʥʰʩʤ
•
ʺʥʰʥʺʧʺʤ ʤʮʩʹʰʤ ʩʫʸʣʡ ʤʬʧʮʬ ʭʥʸʢʬ
ʬʥʫʩ ʩʺʮʩʹʰ ʩʬʠʩʶʰʩʱ ʱʥʸʩʥ
-
ʬʹ ʭʥʤʩʦ
ʳʥʢʤ ʬʹ ʭʩʸʧʠ ʭʩʷʬʧʥ ʺʥʠʩʸʤ
ʤʮʩʹʰʡ ʭʩʲʩʩʱʮʤ
.
ʱʥʸʩʥʡ ʭʥʤʩʦ
ʱ
ʩʺʮʩʹʰ ʩʬʠʩʶʰʩ
ʩʩʥʮʣ ʭʩʬʷ ʭʩʰʮʩʱʬ ʭʸʥʢ ʡʥʸʬʥ ,ʬʩʢ ʬʫʡ
ʹʧʸʺʤʬ ʬʥʫʩ
ʭʩʸʢʥʡʮʡ ʺʥʸʸʷʺ�